Irene Cortes-Puch Selected Research

EC5026

1/2021

Movement to the Clinic of Soluble Epoxide Hydrolase Inhibitor EC5026 as an Analgesic for Neuropathic Pain and for Use as a Nonaddictive Opioid Alternative.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Irene Cortes-Puch Research Topics

Disease

2	Inflammation (Inflammations) 01/2021 - 01/2021
1	Burns 01/2021
1	Infections 01/2021
1	Neuralgia (Stump Neuralgia) 01/2021
1	Pain (Aches) 01/2021
1	COVID-19 01/2021
1	Sepsis (Septicemia) 01/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 07/2020

Drug/Important Bio-Agent (IBA)

2	Unsaturated Fatty Acids (Polyunsaturated Fatty Acids)IBA 01/2021 - 01/2021
2	Epoxy Compounds (Epoxides)IBA 01/2021 - 01/2021
1	Analgesics (Analgesic Drugs)IBA 01/2021
1	Opioid Analgesics (Opioids)IBA 01/2021
1	Cytochrome P-450 Enzyme System (Cytochrome P450)IBA 01/2021
1	Epoxide HydrolasesIBA 01/2021
1	Fatty Acids (Saturated Fatty Acids)IBA 01/2021
1	LipidsIBA 01/2021
1	Linoleic Acid (Linoleate)IBA 01/2021
1	leukotoxinIBA 01/2021
1	EicosanoidsIBA 01/2021
1	EC5026IBA 01/2021
1	Biomarkers (Surrogate Marker)IBA 01/2021

Therapy/Procedure

1	Mechanical Ventilators (Ventilator) 07/2020
1	Therapeutics 07/2020